Inventor
STEINKASSERER ALEXANDER
DE7 patents
⚠️ This page may combine multiple inventors who share the name “STEINKASSERER ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
STEINKASSERER ALEXANDER
5 patentsUS7169898B2Jan 30, 2007
Soluble CD83 proteins and use thereof for the treatment or prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
STEINKASSERER ALEXANDER13 citations79
US8759505B2Jun 24, 2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
STEINKASSERER ALEXANDER2 citations57
US8124099B2Feb 28, 2012
Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
STEINKASSERER ALEXANDER3 citations57
US9102726B2Aug 11, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same
STEINKASSERER ALEXANDER0 citations47
US9822377B2Nov 21, 2017
Mutant CD83 promoter and use thereof
STEINKASSERER ALEXANDER0 citations40
ARGOS THERAPEUTICS INC
2 patentsUS7893200B2Feb 22, 2011
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
ARGOS THERAPEUTICS INC3 citations54
US9732140B2Aug 15, 2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
ARGOS THERAPEUTICS INC0 citations48